Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's disease
- PMID: 40692327
- DOI: 10.1177/18796397251358375
Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's disease
Abstract
BackgroundThe Huntington's Disease (HD) Everyday Functioning (Hi-DEF) is a novel patient-reported outcome (PRO) scale developed to assess the impact of cognitive impairment on daily functioning in early HD patients.ObjectiveTo examine the psychometric properties, including reliability and validity, of the Hi-DEF. Findings from psychometric analyses using classical test theory (CTT) approach are presented here.MethodsA non-interventional validation study was conducted across nine HD Centers of Excellence across the US.ResultsPatients with HD (n = 151) were recruited: 59% were female, mean (SD) age was 47 (12) years, and mean (range) Total Functional Capacity (TFC) score was 11.4 (8-13). Excellent internal consistency reliability was observed for the Hi-DEF scale total score (Cronbach's alpha: 0.98) and across subscales (alpha range 0.87-0.96). Most targeting and scaling assumptions were met, although there were ceiling effects for three subscales. Construct validity was demonstrated by moderate to high Spearman's rank-order correlations with TFC scores (range r = -0.38 to -0.62) and known and validated measures such as the HD-PRO-TRIADTM (range r = 0.75-0.90), and ability to discriminate between levels of functional impairment (TFC 13, 12-11, and 10-8; p < 0.001). Correlations with Cambridge Neuropsychological Test Automated Battery (CANTAB) cognitive performance measures were low to moderate and ranged from 0.06 to 0.38.ConclusionsThe Hi-DEF is a reliable and valid PRO scale measuring the impact of cognitive impairment on daily functioning, assessing facets of cognitive functioning in context of activities of daily living impacted in early stages of HD.
Keywords: Huntington's disease; activities of daily living; executive function; psychometrics; reliability; validity.
Similar articles
-
Cholinesterase inhibitors for rarer dementias associated with neurological conditions.Cochrane Database Syst Rev. 2015 Mar 3;2015(3):CD009444. doi: 10.1002/14651858.CD009444.pub3. Cochrane Database Syst Rev. 2015. PMID: 25734590 Free PMC article.
-
Is It Possible to Develop a Patient-reported Experience Measure With Lower Ceiling Effect?Clin Orthop Relat Res. 2025 Apr 1;483(4):693-703. doi: 10.1097/CORR.0000000000003262. Epub 2024 Oct 25. Clin Orthop Relat Res. 2025. PMID: 39466401
-
Rasch Measurement Theory (RMT) Analyses of the Huntington's Disease Everyday Functioning (Hi-DEF) to Evaluate Item Fit and Performance.J Huntingtons Dis. 2024;13(3):385-397. doi: 10.3233/JHD-240001. J Huntingtons Dis. 2024. PMID: 39213085 Free PMC article.
-
Donepezil for vascular cognitive impairment.Cochrane Database Syst Rev. 2004;(1):CD004395. doi: 10.1002/14651858.CD004395.pub2. Cochrane Database Syst Rev. 2004. PMID: 14974068
-
Multi-domain interventions for the prevention of dementia and cognitive decline.Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2. Cochrane Database Syst Rev. 2021. PMID: 34748207 Free PMC article.
LinkOut - more resources
Full Text Sources
Miscellaneous